It cut death from all causes by 28% in a landmark trial — and nobody could explain why. Now scientists are discovering it may be one of the most powerful anti-aging drugs ever prescribed.
In 2007, something unexpected happened inside a clinical trial at Duke University.
The study was straightforward. Researchers were testing whether a once-yearly infusion of zoledronic acid—a bisphosphonate, a class of drugs designed to strengthen bones—could prevent repeat fractures in patients who had already broken a hip. It could. The drug reduced new fractures by 35%.
But that wasn’t the surprise.
When the researchers tallied the mortality data, they found that patients who received the drug were 28% less likely to die from any cause during the study. Not just from fractures. From anything.
The finding, published in the New England Journal of Medicine, stunned the osteoporosis community. A bone drug—reducing death from all causes? The numbers were so unexpected that the lead investigators initially suspected a statistical error. It wasn’t.
Nearly two decades later, the evidence has only grown stronger. And the implications extend far beyond bone health.
Bisphosphonates have two rare side effects: atypical femoral fractures and osteonecrosis of the jaw (ONJ). What’s more, the risk increases the longer you take them. If anyone here is currently on bisphosphonates, please share your experience!
Additionally, bisphosphonates should be avoided during dental implant procedures, as they may lead to implant failure.
Not yet. I had ACDF surgery December 2025. I will likely start January 2027, and take it for a year, then take a break. I may repeat that 1 year course a couple more times when I hit my 70’s… but once I do hit my 70’s there may be more research or superior interventions, in which case I will re-evaluate. I’m speculating that these drugs are more useful later in life anyway 70’s-80’s. YMMV.
It hasn’t been tested in healthy people. Also it may have the same mode as Rapa, so I don’t know about taking both. Nobody does. Not really a no brainer.
Zoledronic acid is currently being investigated for its potential to extend lifespan and healthspan, with animal studies in Drosophila and mice showing that the drug can extend median lifespan by 14–18% and improve physical vitality. This geroprotective effect is believed to be mediated by the inhibition of the enzyme farnesyl pyrophosphate synthase (FPPS) , which reduces oxidative stress and senescence-associated inflammatory markers independent of its bone-protective actions.
While retrospective human data suggests that patients treated with zoledronic acid for osteoporosis experience reduced mortality rates and fewer deaths from pneumonia and cardiovascular events, clinical trials specifically using the drug for longevity extension in humans have not yet been completed. Consequently, while the drug is already approved for annual intravenous infusion to treat osteoporosis, its use specifically for life extension remains experimental and is currently the subject of ongoing repurposing research.
Mechanism : Inhibits FPPS in the mevalonate pathway, reducing cellular senescence and DNA damage.
Animal Evidence : Extended lifespan in flies and improved grip strength in aged mice.
Human Observational Data : Associated with lower all-cause mortality in postmenopausal women receiving annual 5 mg infusions for bone health.
Current Status : Approved for osteoporosis; longevity application is under study for futur toe repurposing
As posted countless time…
“If you wait until you are ready, it is almost certainly too late.” Seth Godin
Thanks for sharing this article. Although the longevity claims (“one of the most powerful anti-aging drugs ever prescribed”!) seem to be overstated, the evidence encourages me to follow my physician’s advice for Reclast infusion for osteoporosis. I’ve already stopped Rapamycin on my doctor’s advice, so it’s good to know that zolendrenic acid may also address Alzheimer’s risk through a different mTOR pathway.
I took Bisphosphonates and in a couple of months my jaw ached like nothing I had ever experienced. I was told that the drug has that effect in 1-2% of people. But I don’t believe I that I am 1-2% of anything. I don’t believe my response was rare. I’d be careful.